Frontlight ResearchEarly access
SuspendedNo phase
A Novel Computer-Based Therapy for Social Anxiety
Key facts
- Who runs it
- New York State Psychiatric Institute
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Suspended
- People taking part
- 60 people, planned
- Started
- 25 Aug 2017
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- GC-MRT
- modified GC-MRT
- Non-GC-MRT
- Record updated
- 4 February 2026
- Why it stopped
- funding unavailable
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Males and females between the ages of 18 and 60
- Current DSM-V primary diagnosis of SAD
- Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)
- Fluent in English and willing and able to give informed written consent and participate responsibly in the protocol
- Normal or corrected-to-normal vision
Who cannot take part
- Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in the past 3 months
- Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body (e.g. pacemaker, paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant medicinal patch, some tattoos)
- Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
- Current diagnosis of PTSD, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
- Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
- Current unstable or untreated medical illness
- Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders allowed)
- Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for a least 3 months
- Current severe depression
- Suicidal ideation or behavior
- Pregnancy, or plans to become pregnant during the period of the study - will be assessed by Urine β-HCG
- Contraindication to MRI scanning:
- Being unable to tolerate the scanning procedures (i.e., severe obesity, claustrophobia)
Where in United States
- New York State Psychiatric InstituteNew York, United States
About the trial
What the trial wants to find out
The present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD)
The 3 groups in the trial
- GC-MRTTreatment being tested
Group 1 will receive a 4-week (8-sessions) course of standard GC-MRT
- non-GC-MRTExisting treatment, for comparison
Group 2 will receive a 4-week (8-sessions) course of non-GC-MRT
- GC-MRT-modifiedTreatment being tested
Group 3 will receive a 4-week (8-sessions) course of modified GC-MRT.
Treatment: modified GC-MRT
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 4 February 2026